Read + Share
Tribukait B. Early prediction of pathologic response to neoadjuvant treatment of breast
cancer: use of a cell-loss metric based on serum thymidine kinase 1 and tumour
volume. BMC Cancer 2020;20:440.
PMID: 32423477
|
 |
|
Tribukait B. Early prediction of pathologic response to neoadjuvant treatment of breast
cancer: use of a cell-loss metric based on serum thymidine kinase 1 and tumour
volume. BMC Cancer 2020;20:440.
PMID: 32423477
|
|
|
|